Jonathan Graham

5PUBLICATIONS
22CO-AUTHORS
Adolescent healthPoverty, inclusivity and wellbeingDisease surveillanceMedical infection agents (incl. prions)Preventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 06, 2026
Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States.

Oscar Herrera-Restrepo, Ginita Jutlla, Jonathan Graham

|Mar 12, 2025
Market and Non-Market Productivity Losses Associated with Invasive Meningococcal Disease in the USA.

Hiral Anil Shah, Ginita Jutlla, Oscar Herrera-Restrepo

|Dec 09, 2024
Cost-effectiveness of the adjuvanted RSVPreF3 vaccine among adults aged ≥60 years in the United States.

Elizabeth M La, Jonathan Graham, David Singer

|Nov 25, 2024
Public Health Impact of Introducing a Pentavalent Vaccine Against Invasive Meningococcal Disease in the United States.

Hiral Anil Shah, Ginita Jutlla, Oscar Herrera-Restrepo

|Mar 20, 2024
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States.

Daniel Molnar, Elizabeth M La, Frederik Verelst

Pageof 1

Frequent Collaborators

3 joint publications

Frederik Verelst

3 joint publications

Zeki Kocaata

3 joint publications

Hiral Shah

3 joint publications

Ginita Jutlla